Open AccessErratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer?
Author(s) -
Joan T. Garrett,
Anindita Chakrabarty,
Carlos L. Arteaga
Publication year - 2018
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.26017
Subject(s) - pi3k/akt/mtor pathway , medicine , cancer , cancer research , pharmacology , bioinformatics , oncology , chemistry , signal transduction , biology , biochemistry